Rik J. Scheper - Concepedia

Author

Rik J. Scheper

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

R J SCHEPER, R J Scheper, R Scheper, R. J. SCHEPER, R. J. Scheper, R. Scheper, R.J Scheper, R.J. Scheper, RIK J. SCHEPER, RJ Scheper

510

Publications

33.6K

Citations

H-Index

256

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam University of Amsterdam Vrije Universiteit Amsterdam The Netherlands Cancer Institute Amsterdam UMC Location University of Amsterdam

About

Rik J. Scheper is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	62	157	16.3K
2	Natural Sciences	10	10	4K
3	Engineering	7	7	426
4	Health Sciences	7	7	1.4K
5	Public Health	7	7	581

Rik J. Scheper

308

Publications

29.7K

Citations

H-Index

Page 1

	Year	Citations
Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Marcel Kool, Marcel de Haas, George L. Scheffer, PubMed Molecular BiologyCancer BiologyTumor BiologyDrug ResistanceCancer Cell Biology	1997	898
Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene Coen C. Paulusma, Piter J. Bosma, Guido J.R. Zaman, Science GeneticsPathologyMolecular BiologyDisease Gene IdentificationDrug Resistance	1996	830
The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria Johan W. Jonker, Marije Buitelaar, Els Wagenaar, Proceedings of the National Academy of Sciences	2002	816
The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. G J Zaman, M J Flens, Manuel R. van Leusden, Proceedings of the National Academy of Sciences Molecular PharmacologyProtein MrpDrug Resistance AnalysisProteinlipid InteractionBiochemistry	1994	690
MRP3, an organic anion transporter able to transport anti-cancer drugs Marcel Kool, Marcel van der Linden, Marcel de Haas, Proceedings of the National Academy of Sciences	1999	647
Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Michael Müller, Coby Meijer, G J Zaman, Proceedings of the National Academy of Sciences Drug Resistance AnalysisBiochemistryMedicineNatural SciencesLipid Peroxidation	1994	622
The drug resistance-related protein LRP is the human major vault protein George L. Scheffer, Peter Wijngaard, Marcel J. Flens, Nature Medicine Protein FunctionDrug TargetBiochemistryMedicinePeptide Library	1995	617
Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy. William S. Dalton, Thomas M. Grogan, Paul S. Meltzer, Journal of Clinical Oncology ImmunologyContinuous Infusion VerapamilPathologyPharmacotherapyImmunotherapy	1989	560
A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome Coen C. Paulusma, Marcel Kool, Piter J. Bosma, Hepatology GeneticsMolecular BiologyMolecular GeneticsCholangiopathiesMendelian Disorder	1997	555
A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors. Giuseppe Giaccone, Cornelis J. A. Punt, Rita Ruijter, PubMed	2002	507

Page 1